Apoptosis: a new pharmacodynamic endpoint.
Au
J L
JL
College of Pharmacy and Comprehensive Cancer Center, Ohio State University, Columbus 43210, USA.
Panchal
N
N
Li
D
D
Gan
Y
Y
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects* / Q000235:genetics; D002453:Cell Cycle / Q000235:genetics; D003546:Cysteine Endopeptidases / Q000378:metabolism; D004249:DNA Damage; D053938:DNA Fragmentation; D004587:Electrophoresis, Agar Gel; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000648:ultrastructure; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D000970:Antineoplastic Agents; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53; D003546:Cysteine Endopeptidases